Skip to the page

Data / Form D filings / Vinci Pharmaceuticals, Inc.

Vinci Pharmaceuticals, Inc.: Form D filings

Vinci Pharmaceuticals, Inc., a health care company in Avon By The Sea, NJ, filed 2 Form D notices with the SEC between 2019 and 2026. The latest, on January 26, 2026, reports $20.2 million sold of a $25.3 million offering to 53 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
12 Washington Avenue, Avon By The Sea, NJ, 07717
Phone
(914) 582-8305
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1785495

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 26, 2026New notice$25,348,339$20,218,331$5,130,00853Jan 2, 2026sec.gov
Aug 15, 2019New notice$4,000,000$1,000,000$3,000,0001Aug 2, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Philip GioiaExecutive Officer, Director
Sarah HassanDirector
Sigurd KirkDirector
Richard LindstromDirector
Neil Austrian Jr.Director

Other health care companies in New Jersey that filed recently

Every Form D from the week of Jan 26, 2026 · All recent filings in New Jersey · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Vinci Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.